Overview
- Commentators and Bank of America analysts recommend increasing allocations to high‑quality dividend names as the market trades sideways and near‑term risks stay elevated.
- Yahoo Finance singled out AbbVie, Chevron, and PepsiCo as timely dividend opportunities, citing AbbVie's rebound from Humira pressure driven by immunology drugs Skyrizi and Rinvoq.
- Bank of America updated a seven‑stock buy list that includes UnitedHealth, Chevron, Coca‑Cola, Procter & Gamble, Home Depot, Merck, and IBM with buy ratings and explicit price targets for several names.
- Analysts point to Chevron’s roughly 3.7–3.75% forward yield, nearly 40 years of consecutive dividend increases and its 2025 Hess acquisition as reasons it stands out for income investors.
- Coverage stresses that dividends have long powered a large share of total market returns, so investors seeking lower volatility and income may view these blue chips as long‑term defensive holdings.